Area of research
Immunology · Genetics
Research interest
Research focused on Glioma and Temozolomide, with related work in Demography, Placebo, Menarche. Notable publications include 'A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma', 'Reproductive factors and risk of primary brain tumors in women', and 'Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment'.
Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics
Methylmercury exposure, genetic variation in metabolic enzymes, and the risk of glioma
Complementary therapy and survival in glioblastoma
Reproductive factors and risk of primary brain tumors in women
A randomized, double-blind, placebo-controlled phase 2 trial of dendritic cell (DC) vaccination with ICT-107 in newly diagnosed glioblastoma (GBM) patients.
Anthropometric factors in relation to risk of glioma
Early life exposures and the risk of adult glioma